EGFR and breast carcinoma: CD44v6 is one of the CD44 isoforms and, in breast cancer, its overexpression in endocrine sensitive breast cancer cells has been connected to the activation of epidermal growth factor receptor (EGFR) signalling, to an increased invasive ability, as well as to a decrease in response to endocrine therapy [111,112,113].